Press releases 2002
Click on any of the titles in the list below to view that press release in full. If you have difficulty locating the press release you are looking for, you can use the search engine at the top right hand side of the screen.
-
2002/68 NICE Citizens Council issues first ´common sense´ health report
20/12/2002
-
2002/067 NICE asks public, health professionals and NHS: what conditions and treatments would you like NICE to develop guidance on?
19/12/2002
-
2002/066 NICE issues guidance on vinorelbine for advanced breast cancer
16/12/2002
-
2002/064 NICE welcomes changes to topic selection process
05/12/2002
-
2002/063 NICE provides the NHS and people with diabetes with guidance on long-acting insulin
06/12/2002
-
2002/062 First clinical guideline from NICE sets out recommendations for NHS care in schizophrenia
04/12/2002
-
2002/061 First meeting of NICE Citizens Council will discuss clinical need
22/11/2002
-
2002/59 World Diabetes Day: continued commitment to improve diabetes treatment from NICE
14/11/2002
-
2002/58 NICE announces membership of Interventional Procedures Advisory Committee
12/11/2002
-
2002/057 Members of NICE Citizens Council react to appointment
08/11/2002
-
2002/ 056 NICE announces members of first UK Citizens Council
08/11/2002
-
2002/055 NICE issues national guidelines for the management of blood pressure and lipids in people with type 2 diabetes
31/10/2002
-
2002/054 NICE issues guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction
30/10/2002
-
2002/053 NICE issues guidance on computerised cognitive behavioural therapy for anxiety and depression
24/10/2002
-
2002/052 Imatinib (Glivec) is NICE´s 50th Technology Appraisal Guidance
16/10/2002
-
2002/051 Photodynamic therapy
14/10/2002
-
2002/050 NICE issues guidance in two specialist areas to improve choice and care for NHS patients in England and Wales
04/10/2002
-
2002/049 Appointment of Professor Leon Fine as Non-executive Director of NICE
03/10/2002
-
2002/048 Outstanding public response to join NICE´s Citizens Council
24/09/2002
-
2002/047 NICE issues national guidelines for the management of blood glucose levels in people with type 2 diabetes
17/09/2002
-
2002/046 NICE updates glycoprotein IIb/IIIa inhibitor guidance for acute coronary syndromes
05/09/2002
-
2002/45 Consultation on possible topics for NICE work programme
23/08/2002
-
2002/044A UK´s first Citizens Council being established by NICE
19/08/2002
-
2002/044B Have your say in health
19/08/2002
-
2002/043 Final appraisal determination on imatinib (Glivec) for chronic myeloid leukaemia
12/08/2002
-
2002/042 Photodynamic therapy for age-related macular degeneration
25/07/2002
-
2002/041 NICE issues guidance on surgery for morbid obesity
19/07/2002
-
2002/040 NICE issues guidance on the use of PLDH (Caelyx) for ovarian cancer
19/07/2002
-
2000/039 NICE recruits new members to independent advisory committee on the use of health technologies
11/07/2002
-
2002/038 NICE considers appeals following consultation on human growth hormone for adults
08/07/2002
-
2002/037 NICE Response to Select Committee Report
03/07/2002
-
2002/036 NICE considers appeals following consultation on Final Appraisal Determination on photodynamic therapy for age-related macular degeneration
01/07/2002
-
2002/035 Update on NICE appraisal of Human Growth Hormone for Adults
24/06/2002
-
2002/034 NICE recommends the selective use of metal on metal hip resurfacing
19/06/2002
-
2002/033 NICE has not issued guidance or recommendations to NHS on photodynamic therapy
13/06/2002
-
2002/032 Surgery for Obesity: press reports
09/06/2002
-
2002/031 NICE responds to criticisms over guidance on colorectal cancer drugs
07/06/2002
-
2002/030 NICE recommends newer antipsychotic drugs as one of the first line options for schizophrenia
06/06/2002
-
2002/029 David Pink moves from NICE to take up Chief Executive post at the Long Term Medical Conditions Alliance
22/05/2002
-
2002/028 NICE launches guidance on Human Growth Hormone for Children
22/05/2002
-
2002/027 NICE welcomes new topics for work programme
20/05/2002
-
2002/026 NICE launches National Clinical Audit of epilepsy-related death
20/05/2002
-
2002/025 Reactive press release - appraisal of imatinib for chronic myeloid leukaemia
15/05/2002
-
2002/024 NICE issues guidance for RhD-negative women during pregnancy
10/05/2002
-
2002/023 NICE recommends use of treatment for severe Crohn's disease to be available through NHS in England and Wales.
03/05/2002
-
2002/022 NICE and Photodynamic therapy
11/04/2002
-
2002/021 NICE recommends use of smoking cessation therapies
11/04/2002
-
2002/020 NICE issues guidance on inhalers for older children with chronic asthma
11/04/2002
-
2002/019 NICE welcomes responsibility for Safety and Efficacy of New Interventional Procedures
02/04/2002
-
2002/018 NICE recommends the selective use of rituximab for follicular non-Hodgkins lymphoma
28/03/2002
-
2002/017 Professor Parveen Kumar moves to Medicines Commission
27/03/2002
-
2002/016 NICE recommends the selective use of new drugs for arthritis in children and adults
22/03/2002
-
2002/015 NICE recommends trastuzumab (Herceptin) for advanced breast cancer
15/03/2002
-
2002/014 NICE and CHI launch handbook to help NHS staff improve standards following the Bristol Royal Inquiry
08/03/2002
-
2002/013 NICE recommends selective use of drugs for advanced colorectal cancer
07/03/2002
-
2002/012 NICE welcomes announcement of consultation on the timing and selection of topics for NICE appraisal
05/03/2002
-
2002/011 NICE issues national guidelines to help reduce blindness and kidney disease
05/03/2002
-
2002/010 NICE and CHI to launch audit handbook to help NHS staff improve standards
12/02/2002
-
2002/009 NICE consults with stakeholders on changes to the technology appraisal appeal process
11/02/2002
-
2002/008 NICE launches enhanced consultation process: First appraisal under new process will be ovarian cancer drug Caelyx
08/02/2002
-
2002/007 NICE issues guidance on drugs for multiple sclerosis
04/02/2002
-
2002/006 NICE commences quantitative market research among stakeholders as part of its review of dissemination
01/02/2002
-
2002/005 NICE present evidence to Health Select Committee
30/01/2002
-
2002/004 NICE responds to comments made by Mr Paul Burstow MP
25/01/2002
-
2002/003 Appeal Decision: Technology Appraisal on the use of beta interferon and glatiramer
25/01/2002
-
2002/002 NICE responds to Comments made by Director of the Cancer Research Campaign.
17/01/2002
-
2002/001 NICE responds to Government announcement on the Report of the Bristol Royal Infirmary Inquiry
17/01/2002
This page was last updated: 01 July 2009
